Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix

K Heselmeyer, E Schröck, S du Manoir, H Blegen, K Shah, R Steinbeck, G Auer, T Ried, K Heselmeyer, E Schröck, S du Manoir, H Blegen, K Shah, R Steinbeck, G Auer, T Ried

Abstract

We have chosen tumors of the uterine cervix as a model system to identify chromosomal aberrations that occur during carcinogenesis. A phenotype/genotype correlation was established in defined regions of archived, formalin-fixed, and hematoxylin/eosin-stained tissue sections that were dissected from normal cervical epithelium (n = 3), from mild (n = 4), moderate (n = 6), and severe dysplasias/carcinomas in situ (CIS) (n = 13), and from invasive carcinomas (n = 10) and investigated by comparative genomic hybridization. The same tissues were analyzed for DNA ploidy, proliferative activity, and the presence of human papillomavirus (HPV) sequences. The results show that an increase in proliferative activity and tetraploidization had occurred already in mildly dysplastic lesions. No recurrent chromosomal aberrations were observed in DNA extracted from normal epithelium or from mild and moderate dysplasias, indicating that the tetraploidization precedes the loss or gain of specific chromosomes. A gain of chromosome 3q became visible in one of the severe dysplasias/CIS. Notably, chromosome 3q was overrepresented in 90% of the carcinomas and was also found to have undergone a high-level copy-number increase (amplification). We therefore conclude that the gain of chromosome 3q that occurs in HPV16-infected, aneuploid cells represents a pivotal genetic aberration at the transition from severe dysplasia/CIS to invasive cervical carcinoma.

References

    1. Hum Mol Genet. 1993 Nov;2(11):1907-14
    1. Cancer. 1994 Feb 1;73(3):664-71
    1. Cancer Res. 1994 Feb 1;54(3):637-9
    1. J Infect Dis. 1994 Feb;169(2):235-40
    1. Cancer Res. 1994 Apr 1;54(7):1801-6
    1. Lancet. 1994 Apr 16;343(8903):955-7
    1. Am J Pathol. 1994 Jun;144(6):1203-18
    1. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):6953-7
    1. Am J Hum Genet. 1995 Mar;56(3):705-15
    1. Cytometry. 1995 Jan 1;19(1):27-41
    1. Acta Oncol. 1995;34(2):171-6
    1. J Natl Cancer Inst. 1995 Jun 7;87(11):796-802
    1. Cancer Res. 1995 Nov 15;55(22):5415-23
    1. J Chronic Dis. 1958 Jul;8(1):2-37
    1. Hum Genet. 1993 Feb;90(6):590-610
    1. Hereditas. 1971;68(2):165-218
    1. Science. 1976 Oct 1;194(4260):23-8
    1. Nature. 1985 May 16-22;315(6016):190-5
    1. Science. 1989 Feb 17;243(4893):934-7
    1. Hum Pathol. 1989 Jun;20(6):518-27
    1. Cancer Res. 1989 Jul 1;49(13):3598-601
    1. Cancer Genet Cytogenet. 1990 Feb;44(2):229-41
    1. Cell. 1990 Jun 1;61(5):759-67
    1. Cell. 1990 Dec 21;63(6):1129-36
    1. Cell. 1991 Jan 25;64(2):235-48
    1. Am J Hum Genet. 1991 Oct;49(4):868-77
    1. Cancer Genet Cytogenet. 1992 Jun;60(2):214-5
    1. Science. 1992 Oct 30;258(5083):818-21

Source: PubMed

3
Tilaa